enEvolv, Inc. specializes in engineering and licensing microorganisms, including bacteria, yeast, and algae, to produce chemicals, enzymes, and small molecules for various industries such as specialty chemicals, food, energy, personal care, and pharmaceuticals. Founded in 2011 and based in Boston, Massachusetts, enEvolv addresses the growing global demand for essential resources due to population growth and economic development. The company collaborates with other businesses to engineer novel microorganisms and enhance existing strains, aiming to increase production yield and product quality. Utilizing its proprietary genome engineering platform, which employs Multiplex Automated Genome Engineering (MAGE) technology developed at Harvard, enEvolv accelerates the evolution of living cells, offering significant advantages in speed, cost, and engineering capabilities. As of March 2020, enEvolv operates as a subsidiary of Zymergen, Inc.
Radiant Genomics, Inc. is a company that specializes in software development for natural product and gene discovery. Founded in 2012 and based in Emeryville, California, it offers a synthetic biology platform that enables scientists to identify, produce, and test products encoded in the genomes of organisms that are challenging to cultivate in laboratory settings. The company provides a range of services, including gene sequencing, synthetic biology, and metabolic engineering, aimed at facilitating industrial access to the chemistry found in natural organisms. Its targeted markets encompass agriculture, pharmaceuticals, and specialty chemicals. As of January 2018, Radiant Genomics operates as a subsidiary of Zymergen, Inc.